Optimization of active surveillance strategies for heterogeneous patients with prostate cancer-Reference-Cited by-同舟云学术

Optimization of active surveillance strategies for heterogeneous patients with prostate cancer

Published:2022-07-31 Issue:11 Volume:31 Page:4021-4037
ISSN:1059-1478
Container-title:Production and Operations Management
language:en
Short-container-title:Production & Oper Manag

Author:

Zhang Zheng¹^ORCID,Denton Brian T.²^ORCID,Morgan Todd M.³

Affiliation:

1. Department of Service Science and Operations Management Zhejiang University Hangzhou Zhejiang China

2. Department of Industrial and Operations Engineering University of Michigan Ann Arbor Michigan USA

3. Division of Urologic Oncology, Urology University of Michigan Ann Arbor Michigan USA

Funder

National Natural Science Foundation of China

Fundamental Research Funds for the Central Universities

National Science Foundation

Publisher

Wiley

Subject

Management of Technology and Innovation,Industrial and Manufacturing Engineering,Management Science and Operations Research

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/poms.13800

Reference45 articles.

1. Scalable Planning and Learning for Multiagent POMDPs

2. Sensitivity and specificity of prostate‐specific antigen for prostate cancer detection with high rates of biopsy verification;Ankerst D. P.;Archivio Italiano di Urologia Andrologia,2006

3. United States Life Tables, 2012;Arias E.;National Vital Statistics Reports,2016

4. OR Forum—A POMDP Approach to Personalize Mammography Screening Decisions

5. Optimizing active surveillance strategies to balance the competing goals of early detection of grade progression and minimizing harm from biopsies

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multi-stage probabilistic linguistic matching method with the screening mechanism and individual preference relationship fusion;Journal of the Operational Research Society;2024-02-07

2. Screening Process Information Matters More Than Clinical Information: A Randomized Controlled Trial of Information Sharing on Cancer Screening Decision;2024